Canopy Growth Corporation (CGC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.96
+4.48%
Mkt Cap $387.24M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$14.47
Range $8.00 – $27.85
Implied Upside
+1409.8%
Consensus $14.47 vs current $0.96